Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bernhard

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|August 15, 1992
Activity of recombinant mitogillin and mitogillin immunoconjugatesM Better, S L Bernhard, S P Lei, et al.
Research in Nursing & Health|February 25, 2000
Continuous handrail support, oxygen uptake, and heart rate in women during submaximal step treadmill exerciseS K Christman, A F Fish, L Bernhard, et al.
Bioconjugate Chemistry|May 1, 1994
Enhanced stability in vitro and in vivo of immunoconjugates prepared with 5-methyl-2-iminothiolaneS F Carroll, S L Bernhard, D A Goff, et al.
The Journal of Biological Chemistry|April 1, 1994
Gelonin analogs with engineered cysteine residues form antibody immunoconjugates with unique propertiesM Better, S L Bernhard, D M Fishwild, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1993
Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2M Better, S L Bernhard, S P Lei, et al.
The Journal of Biological Chemistry|June 23, 1995
T cell-targeted immunofusion proteins from Escherichia coliM Better, S L Bernhard, R E Williams, et al.
Bone Marrow Transplantation|October 31, 2002
A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantationB J Bolwell, M Kalaycio, R Sobecks, et al.
Biopharmaceutics & Drug Disposition|December 1, 1996
Alteration of the pharmacokinetics of small proteins by iodinationR J Bauer, S D Leigh, C A Birr, et al.
Bioconjugate Chemistry|March 1, 1994
Cysteine analogs of recombinant barley ribosome inactivating protein form antibody conjugates with enhanced stability and potency in vitroS L Bernhard, M Better, D M Fishwild, et al.
Nature Biotechnology|July 1, 1996
High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic miceD M Fishwild, S L O'Donnell, T Bengoechea, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|August 15, 1992
Activity of recombinant mitogillin and mitogillin immunoconjugatesM Better, S L Bernhard, S P Lei, et al.
Research in Nursing & Health|February 25, 2000
Continuous handrail support, oxygen uptake, and heart rate in women during submaximal step treadmill exerciseS K Christman, A F Fish, L Bernhard, et al.
Bioconjugate Chemistry|May 1, 1994
Enhanced stability in vitro and in vivo of immunoconjugates prepared with 5-methyl-2-iminothiolaneS F Carroll, S L Bernhard, D A Goff, et al.
The Journal of Biological Chemistry|April 1, 1994
Gelonin analogs with engineered cysteine residues form antibody immunoconjugates with unique propertiesM Better, S L Bernhard, D M Fishwild, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1993
Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2M Better, S L Bernhard, S P Lei, et al.
The Journal of Biological Chemistry|June 23, 1995
T cell-targeted immunofusion proteins from Escherichia coliM Better, S L Bernhard, R E Williams, et al.
Bone Marrow Transplantation|October 31, 2002
A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantationB J Bolwell, M Kalaycio, R Sobecks, et al.
Biopharmaceutics & Drug Disposition|December 1, 1996
Alteration of the pharmacokinetics of small proteins by iodinationR J Bauer, S D Leigh, C A Birr, et al.
Bioconjugate Chemistry|March 1, 1994
Cysteine analogs of recombinant barley ribosome inactivating protein form antibody conjugates with enhanced stability and potency in vitroS L Bernhard, M Better, D M Fishwild, et al.
Nature Biotechnology|July 1, 1996
High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic miceD M Fishwild, S L O'Donnell, T Bengoechea, et al.
Pageof 3